Volume | 782 |
|
|||||
News | (1) | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
West Pharmaceutical Services Inc | WST | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
354.41 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
20 | 782 | - | 310.42 - 415.73 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
07:31:56 | 20 | US$ 356.00 | USD |
West Pharmaceutical Serv... (WST) Options Flow Summary
West Pharmaceutical Services Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
25.98B | 73.30M | - | 2.95B | 593.4M | 8.10 | 43.78 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
West Pharmaceutical Serv... News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical WST Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 380.00 | 394.42 | 353.63 | 371.79 | 603,355 | -24.00 | -6.32% |
1 Month | 388.86 | 396.75 | 353.63 | 378.98 | 413,789 | -32.86 | -8.45% |
3 Months | 398.49 | 413.70 | 325.735 | 375.76 | 533,495 | -42.49 | -10.66% |
6 Months | 324.10 | 413.70 | 310.42 | 363.20 | 487,335 | 31.90 | 9.84% |
1 Year | 363.93 | 415.73 | 310.42 | 366.45 | 424,752 | -7.93 | -2.18% |
3 Years | 324.84 | 475.35 | 206.19 | 339.17 | 454,721 | 31.16 | 9.59% |
5 Years | 122.15 | 475.35 | 113.04 | 286.05 | 463,852 | 233.85 | 191.44% |
West Pharmaceutical Serv... Description
West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (82% of 2021 sales) and contract-manufactured products (18%). It generates 55% of its revenue from international markets and 45% from the United States. |